Universitätsklinikum Schleswig-Holstein;Campus Lübeck

Lübeck, Schleswig-Holstein 23562

3 studies enrolling now · 10 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Melanoma, Atrial Fibrillation, Bleeding, Brain Diseases, Breast Cancer, Cancer, Cardiovascular Diseases, Central Nervous System Diseases, Cerebrovascular Disorders, Chronic Myelomonocytic Leukemia, Ischemia

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. — Recruiting now
• A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) — Enrolling by invitation
• A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study — Running, not enrolling
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors — Stopped early
• Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma — Completed
• Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment — Completed
• pRESET for Occlusive Stroke Treatment — Completed